title: Bendamustine as a bridge to allogeneic transplant in relapsed/refractory Hodgkin lymphoma patients who failed salvage brentuximab vedotin postautologous peripheral blood stem cell transplantation.
authors.affiliation: a Division of Hematology and Oncology, Department of Internal Medicine , American University of Beirut Medical Center , Beirut , Lebanon.
authors.forename: Jean
authors.initials: J
authors.lastname: El Cheikh
authors.affiliation: a Division of Hematology and Oncology, Department of Internal Medicine , American University of Beirut Medical Center , Beirut , Lebanon.
authors.forename: Radwan
authors.initials: R
authors.lastname: Massoud
authors.affiliation: a Division of Hematology and Oncology, Department of Internal Medicine , American University of Beirut Medical Center , Beirut , Lebanon.
authors.forename: Basel
authors.initials: B
authors.lastname: Haffar
authors.affiliation: a Division of Hematology and Oncology, Department of Internal Medicine , American University of Beirut Medical Center , Beirut , Lebanon.
authors.forename: Elie
authors.initials: E
authors.lastname: Fares
authors.affiliation: a Division of Hematology and Oncology, Department of Internal Medicine , American University of Beirut Medical Center , Beirut , Lebanon.
authors.forename: Rami
authors.initials: R
authors.lastname: Mahfouz
authors.affiliation: b Division of Hematology and Oncology , Makassed University hospital , Beirut , Lebanon.
authors.forename: Tamima
authors.initials: T
authors.lastname: Jisr
authors.affiliation: c Department of Blood and Marrow Transplantation , H. Lee Moffitt Cancer Center , Tampa, FL , USA.
authors.forename: Mohamed A
authors.initials: MA
authors.lastname: Kharfan-Dabaja
authors.affiliation: b Division of Hematology and Oncology , Makassed University hospital , Beirut , Lebanon.
authors.forename: Anas
authors.initials: A
authors.lastname: Mougharbel
authors.affiliation: b Division of Hematology and Oncology , Makassed University hospital , Beirut , Lebanon.
authors.forename: Ali
authors.initials: A
authors.lastname: Youssef
authors.affiliation: a Division of Hematology and Oncology, Department of Internal Medicine , American University of Beirut Medical Center , Beirut , Lebanon.
authors.forename: Ali
authors.initials: A
authors.lastname: Bazarbachi
authors.affiliation: b Division of Hematology and Oncology , Makassed University hospital , Beirut , Lebanon.
authors.forename: Ahmad
authors.initials: A
authors.lastname: Ibrahim
mesh_terms: D000293:Adolescent; D000328:Adult; D000069461:Bendamustine Hydrochloride / Q000008:administration & dosage*; D000079963:Brentuximab Vedotin; D003131:Combined Modality Therapy; D006689:Hodgkin Disease / Q000000981:diagnostic imaging / Q000473:pathology* / Q000628:therapy*; D006801:Humans; D018796:Immunoconjugates / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D009367:Neoplasm Staging; D036102:Peripheral Blood Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods; D000072078:Positron Emission Tomography Computed Tomography; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D018796:Immunoconjugates; D000079963:Brentuximab Vedotin; D000069461:Bendamustine Hydrochloride